Chlorthalidone in CKD, Factor XI Inhibition for VTE Prevention, Untreated Subsegmental PE and Risk of Recurrent VTE, Rivaroxaban and GI Bleeding, Mental Stress Induced Ischemia, Depression and Residency, Patient Outcomes for Part Time Hospitalists
Somehow we got through 7 articles today, and none of them are about COVID-19! Happy Thanksgiving! Chlorthalidone in CKDMilvexian for VTE PreventionRisk of Recurrent VTE in Subsegmental PERivaroxaban associated with higher rates of GI bleedingDepression and ResidencyMental-Stress Induced Myocardial …
TIMI Talks S2E2 – Factor XI Inhibition and AZALEA-TIMI 71 with Dr. Christian Ruff
https://timi.org/wp-content/uploads/2023/11/S2E2-Christian-Ruff.mp3
Dr. Christian Ruff joins the podcast to discuss Factor XI inhibition and his recent Late-Breaking Clinical Trial presentation at AHA, the AZALEA-TIMI 71 trial.
Anticoagulation, Thombin Generation and Factor XI inhibition in ACS and Atrial Fibrillation with Dr C. Michael Gibson
We would love to hear your thoughts on the episodes!
Dr. Thomas Nero discusses current therapy with Factor X inhibitors, the new research with Factor XI inhibition and specifically the enrolling Milvexian clinical trials with Dr. C Micahel Gibson. In addition they discuss, the addition of these me…
Cardiology 2024 Highlights and Predictions for 2025
Drs Harrington and Gibson review their picks for the top cardiology trials of 2024 and look ahead to 2025, particularly what health topics may be prioritized by the new administration.
This podcast is intended for healthcare professionals only.
To read a transcript or to comment https://www.medsc…
Factor XI Inhibition- Milvexian, Asundexian, and AXIOMATIC
CME credits: 1.00
Valid until: 30-09-2023
Claim your CME credit at https://reachmd.com/programs/cme/factor-xi-inhibition-milvexian-asundexian-and-axiomatic/14443/
In this program, expert faculty review and discuss real-world applications of the latest practice-changing data across differe…
Stroke Alert January 2022
On Episode 12 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the January 2022 issue of Stroke: "Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study" and "Cumulative Concussion and Odds of Stroke in Former Na…
Long-acting Factor XI Inhibition and Peri-procedural Bleeding: An Analysis from AZALEA-TIMI 71 | JACC
In this episode, Dr. Valentin Fuster explores groundbreaking research on long-acting Factor XI inhibitors, highlighting their potential to reduce bleeding risks during invasive procedures in patients with atrial fibrillation. Experts discuss the promising safety profile and the ongoing quest to bal…
7 7 2025
Hi, This Week in Medicine, we will be discussing
New England Journal of Medicine
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Ca…
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Faculty: Mukul Sharma, MD, MSc, FRCPC
Faculty: Ashkan Shoamanesh, MD, MSc, FRCPC
Preventing stroke is critical, but for many patients, the fear of uncontrolled bleeding stands in the way of anticoagulation. What if we didn’t have to choose? Explore the emerging role of Factor XI/XIa …
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME credits: 0.75
Valid until: 06-05-2027
Claim your CME credit at https://reachmd.com/programs/cme/secondary-stroke-prevention-emerging-role-factor-xi-inhibition/50969/
Preventing stroke is critical, but for many patients, the fear of uncontrolled bleeding stands in the way of anticoagul…
पॉडकास्ट खोज इंजन
आप लोगों, स्थानों या विषयों के आधार पर3,830,261पॉडकास्ट और196,596,000एपिसोड खोजने के लिए हमारी वेबसाइट का उपयोग कर सकते हैं।
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
संपादित करें
पॉडकास्ट डेटाबेस को अपडेटेड रखने में मदद के लिए धन्यवाद।
